#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phenylketonuria Rhabdomyosarcoma Breast cancer metastatic Cataract Mitochondrial DNA depletion Graft versus host disease Neuroblastoma Cutaneous T-cell lymphoma stage I Adrenogenital syndrome Arterial tortuosity syndrome Congenital pseudarthrosis Richter's syndrome Autoinflammation with infantile enterocolitis Pulmonary sarcoidosis Retinal dystrophy More trials…

    Learn about Rare Diseases

    CADASIL X-linked lymphoproliferative syndrome – Trials in Disease Nodal marginal zone B-cell lymphoma – Diagnostics Chondrosarcoma – Life with Disease Behcet’s syndrome – Basic Information Osteosarcoma – Diagnostics Uterine leiomyosarcoma – Diagnostics Synovial sarcoma metastatic – Diagnostics Haemophagocytic lymphohistiocytosis – Treatment Antithrombin III deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Insulin Human Atenolol Rbl027.2 Ly3556050 Aavanc80-5'Hotof Pacritinib Azacitidine Intestifix Dextrose Bp Nanatinostat 10-1074-Ls Methoxsalen Ambrosia Artemisiifolia (302) Solrikitug Prednisone Acetate Ascorbic Acid D5-Ethyl-Beta-D-Glucuronide Valemetostat Tosilate Cefalexin Monohydrate Pertuzumab More therapies…

    Learn about Your Condition

    Penile squamous cell carcinoma Bone metabolism disorder Head and neck cancer Oral neoplasm Marfan's syndrome Hodgkin's disease recurrent Urethral valves Influenza Cholangitis sclerosing Urticaria cholinergic Metastatic gastric cancer Ovarian epithelial cancer Progressive multiple sclerosis Phenylketonuria Deafness traumatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on PTG-CARCIK-CD19 for Adults and Children with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia refractory
    Investigated Drugs:
    • Ptg-Carcik-Cd19
    Italy

  • Study on Progesterone and Estradiol for Infertility in Patients Undergoing Hormone Replacement Therapy with Frozen Embryo Transfer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Estradiol
    • Progesterone Ph. Eur.
    Denmark

  • Study of Bicalutamide and Abemaciclib for Patients with Advanced Androgen Receptor Positive Triple-Negative Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Bicalutamide
    • Abemaciclib
    Belgium

  • Study on Lowering INR to Reduce Bleeding in Patients with Mechanical Aortic Valves Using Warfarin, Acenocoumarol, and Phenprocoumon

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acenocoumarol
    • Phenprocoumon
    • Warfarin
    Belgium Denmark Germany Italy The Netherlands Spain

  • Study on the Effect of Influenza Vaccine on Heart Inflammation After Heart Attack for Patients with Myocardial Infarction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial infarction
    Investigated Drugs:
    • B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type)
    • Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated
    • Influenza Virus A/Darwin/9/2021 San-010 (H3N2)
    Denmark Sweden

  • Study on Upadacitinib and Tocilizumab for Children and Teens with Active Systemic Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Tocilizumab
    • Upadacitinib
    Austria Belgium Germany Hungary Italy The Netherlands +2
Previous Page
1 … 553 554 555 556 557 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!